Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
HucMSC-Ex alleviates inflammatory bowel disease via the lnc78583-mediated miR3202/HOXB13 pathway
Most significant results occur at 1mg and above
Coverage often limits to patients with a BMI of 30 or higher (or 27+ with weight-related comorbidities)
However, cross-generation and cross-trial comparisons carry inherent limitations: different participant populations, study designs, follow-up durations, titration schedules, and endpoint definitions make direct comparison imperfect
Hausner H, Derving Karsbl J, Holst AG, et al
US$ 26.49
US$ 20.19
US$ 23.27
US$ 22.84
